Clinical adverse events to letairis: a real-world drug safety study based on FDA adverse event reporting system (FAERS)
YT Bi, B Dong - Expert Opinion on Drug Safety, 2024 - Taylor & Francis
Background Letairis (ambrisentan), an endothelin receptor antagonist (ERA), is a critical
medication for pulmonary arterial hypertension (PAH). Despite its efficacy, its safety profile is …
medication for pulmonary arterial hypertension (PAH). Despite its efficacy, its safety profile is …
Analysis of risk factors that influence events hypertension pre-elderly
NJ Hadi, S Saimi - Science Midwifery, 2024 - midwifery.iocspublisher.org
Hypertension is one of disease chronic affects global health, especially in populations pre-
elderly. Identification factor influencing risks incident hypertension at stage pre-elderly can …
elderly. Identification factor influencing risks incident hypertension at stage pre-elderly can …
Factores clínico-epidemiológicos en la evolución clínica de pacientes pediátricos con cardiopatías congénitas
GRG Ojeda, MCS Hernández… - Medicentro Electrónica, 2024 - medicentro.sld.cu
Las cardiopatías congénitas constituyen un problema de salud a nivel mundial y
particularmente en Cuba, ya que a pesar de los avances científicos alcanzados, su impacto …
particularmente en Cuba, ya que a pesar de los avances científicos alcanzados, su impacto …